PL2976089T3 - Zastosowanie sedoheptulozy do zapobiegania lub leczenia zapalenia - Google Patents
Zastosowanie sedoheptulozy do zapobiegania lub leczenia zapaleniaInfo
- Publication number
- PL2976089T3 PL2976089T3 PL14711754.3T PL14711754T PL2976089T3 PL 2976089 T3 PL2976089 T3 PL 2976089T3 PL 14711754 T PL14711754 T PL 14711754T PL 2976089 T3 PL2976089 T3 PL 2976089T3
- Authority
- PL
- Poland
- Prior art keywords
- sedoheptulose
- inflammation
- prevention
- treatment
- Prior art date
Links
- HAIWUXASLYEWLM-UHFFFAOYSA-N D-manno-Heptulose Natural products OCC1OC(O)(CO)C(O)C(O)C1O HAIWUXASLYEWLM-UHFFFAOYSA-N 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- HSNZZMHEPUFJNZ-UHFFFAOYSA-N L-galacto-2-Heptulose Natural products OCC(O)C(O)C(O)C(O)C(=O)CO HSNZZMHEPUFJNZ-UHFFFAOYSA-N 0.000 title 1
- HAIWUXASLYEWLM-AZEWMMITSA-N Sedoheptulose Natural products OC[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@](O)(CO)O1 HAIWUXASLYEWLM-AZEWMMITSA-N 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- HSNZZMHEPUFJNZ-SHUUEZRQSA-N sedoheptulose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO HSNZZMHEPUFJNZ-SHUUEZRQSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13160443.1A EP2781219A1 (en) | 2013-03-21 | 2013-03-21 | Use of sedoheptulose for prevention or treatment of inflammation |
| PCT/EP2014/055679 WO2014147214A1 (en) | 2013-03-21 | 2014-03-21 | Use of sedoheptulose for prevention or treatment of inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2976089T3 true PL2976089T3 (pl) | 2023-01-30 |
Family
ID=47901873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14711754.3T PL2976089T3 (pl) | 2013-03-21 | 2014-03-21 | Zastosowanie sedoheptulozy do zapobiegania lub leczenia zapalenia |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9694026B2 (pl) |
| EP (2) | EP2781219A1 (pl) |
| JP (1) | JP6388635B2 (pl) |
| CN (2) | CN115364112A (pl) |
| AU (1) | AU2014234230B2 (pl) |
| BR (1) | BR112015023463A2 (pl) |
| CA (1) | CA2903151C (pl) |
| DK (1) | DK2976089T3 (pl) |
| ES (1) | ES2930249T3 (pl) |
| HU (1) | HUE060237T2 (pl) |
| MX (1) | MX385322B (pl) |
| NZ (1) | NZ711523A (pl) |
| PL (1) | PL2976089T3 (pl) |
| PT (1) | PT2976089T (pl) |
| WO (1) | WO2014147214A1 (pl) |
| ZA (1) | ZA201506396B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2781218A1 (en) | 2013-03-21 | 2014-09-24 | Medizinische Universität Wien | Use of sedoheptulose as a nutritional supplement |
| CN106309458A (zh) * | 2016-07-28 | 2017-01-11 | 中南大学湘雅医院 | 2‑脱氧‑d‑葡萄糖及其在药学上可接受的盐在制备治疗银屑病药物方面的应用 |
| CN116602363B (zh) * | 2023-06-17 | 2025-01-24 | 广东驱动力生物科技集团股份有限公司 | 一种治疗或预防肉食性鱼脂肪肝的助剂及其制备方法 |
| CN119405681B (zh) * | 2024-11-04 | 2025-09-23 | 新乡医学院 | 核糖-5磷酸在制备治疗炎症性疾病药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0221728B1 (en) * | 1985-10-22 | 1992-07-15 | Anthony N. Silvetti, Sr. | Monosaccharide containing wound healing preparation |
| JPH04335877A (ja) | 1991-05-13 | 1992-11-24 | Eimu:Kk | 十薬食品・飲料並びに製造法 |
| US9492582B2 (en) * | 2000-11-08 | 2016-11-15 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| US20090252834A1 (en) | 2004-05-10 | 2009-10-08 | Michael Griffin Hayek | Compositions comprising glucose anti-metabolites |
| AU2005281300A1 (en) | 2004-07-30 | 2006-03-16 | Pharmed Medicare Pty. Ltd. | Reduced calorie sweetener composition |
| EP1876911A2 (en) | 2005-02-28 | 2008-01-16 | McNeil Nutritionals, LLC | Brown sugar substitute |
| JP5048238B2 (ja) * | 2005-11-16 | 2012-10-17 | エスエス製薬株式会社 | ウワウルシ乾燥エキス含有経口製剤 |
| GB0720516D0 (en) | 2007-10-18 | 2007-11-28 | Cadbury Schweppes Plc | Comestible products |
| KR100912277B1 (ko) * | 2007-11-21 | 2009-08-17 | 한국생명공학연구원 | 내열성 효소를 이용하여 세도헵툴로스를 제조하는 방법 |
| CN101919872B (zh) * | 2010-07-21 | 2011-12-07 | 广东粤龙药业有限公司 | 景酮糖酐在制备抗乙肝药物中的应用 |
| GB201303698D0 (en) | 2012-10-26 | 2013-04-17 | Tate & Lyle Ingredients | Sweetener syrups |
| CN103059071B (zh) * | 2013-01-08 | 2016-03-16 | 华东理工大学 | 一种单糖的纳滤分离方法 |
| EP2781218A1 (en) | 2013-03-21 | 2014-09-24 | Medizinische Universität Wien | Use of sedoheptulose as a nutritional supplement |
-
2013
- 2013-03-21 EP EP13160443.1A patent/EP2781219A1/en not_active Withdrawn
-
2014
- 2014-03-21 DK DK14711754.3T patent/DK2976089T3/da active
- 2014-03-21 AU AU2014234230A patent/AU2014234230B2/en not_active Ceased
- 2014-03-21 EP EP14711754.3A patent/EP2976089B1/en active Active
- 2014-03-21 CN CN202211174309.3A patent/CN115364112A/zh active Pending
- 2014-03-21 BR BR112015023463A patent/BR112015023463A2/pt not_active IP Right Cessation
- 2014-03-21 PL PL14711754.3T patent/PL2976089T3/pl unknown
- 2014-03-21 US US14/778,850 patent/US9694026B2/en active Active
- 2014-03-21 PT PT147117543T patent/PT2976089T/pt unknown
- 2014-03-21 WO PCT/EP2014/055679 patent/WO2014147214A1/en not_active Ceased
- 2014-03-21 ES ES14711754T patent/ES2930249T3/es active Active
- 2014-03-21 HU HUE14711754A patent/HUE060237T2/hu unknown
- 2014-03-21 CA CA2903151A patent/CA2903151C/en active Active
- 2014-03-21 JP JP2016503672A patent/JP6388635B2/ja not_active Expired - Fee Related
- 2014-03-21 NZ NZ711523A patent/NZ711523A/en not_active IP Right Cessation
- 2014-03-21 CN CN201480028530.5A patent/CN105283188A/zh active Pending
- 2014-03-21 MX MX2015013378A patent/MX385322B/es unknown
-
2015
- 2015-09-01 ZA ZA2015/06396A patent/ZA201506396B/en unknown
-
2017
- 2017-06-14 US US15/622,235 patent/US10660910B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE060237T2 (hu) | 2023-02-28 |
| EP2781219A1 (en) | 2014-09-24 |
| CN105283188A (zh) | 2016-01-27 |
| JP6388635B2 (ja) | 2018-09-12 |
| MX385322B (es) | 2025-03-18 |
| DK2976089T3 (da) | 2022-11-07 |
| WO2014147214A1 (en) | 2014-09-25 |
| AU2014234230B2 (en) | 2018-08-09 |
| EP2976089A1 (en) | 2016-01-27 |
| ES2930249T3 (es) | 2022-12-09 |
| US20170281661A1 (en) | 2017-10-05 |
| BR112015023463A2 (pt) | 2017-07-18 |
| US20160045525A1 (en) | 2016-02-18 |
| JP2016516077A (ja) | 2016-06-02 |
| AU2014234230A1 (en) | 2015-09-17 |
| EP2976089B1 (en) | 2022-08-17 |
| ZA201506396B (en) | 2018-05-30 |
| PT2976089T (pt) | 2022-11-22 |
| CA2903151A1 (en) | 2014-09-25 |
| CN115364112A (zh) | 2022-11-22 |
| NZ711523A (en) | 2020-09-25 |
| US10660910B2 (en) | 2020-05-26 |
| CA2903151C (en) | 2021-11-30 |
| US9694026B2 (en) | 2017-07-04 |
| MX2015013378A (es) | 2016-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281793A (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL273815B (en) | Secondary vaccine particles for the treatment of inflammation | |
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| IL243485A0 (en) | Methods for treating or preventing ophthalmological conditions | |
| PL3157511T3 (pl) | Zastosowanie kannabinoidów w leczeniu padaczki | |
| EP3620203C0 (en) | VASCULAR TREATMENT DEVICES | |
| IL243976B (en) | kdm1a inhibitors for disease treatment | |
| SG11201601412XA (en) | Compositions and methods for the treatment of presbyopia | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| IL251904A0 (en) | Apilimod for use in the treatment of melanoma | |
| SG10201705899XA (en) | Prevention & treatment of neuropathy | |
| PL2968478T3 (pl) | Kompozycje i sposoby do leczenia karboksyhemoglobinemii | |
| HUE049301T2 (hu) | Kurkofenol-vegyület rák kezelésére | |
| PL2976089T3 (pl) | Zastosowanie sedoheptulozy do zapobiegania lub leczenia zapalenia | |
| DK2976101T3 (da) | Behandlingsfremgangsmåde | |
| DK3041506T3 (da) | Behandlingsfremgangsmåde | |
| PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
| GB201320653D0 (en) | Treatment of plants | |
| GB201308665D0 (en) | Device for the treatment of bone conditions | |
| GB201319614D0 (en) | Fluid treatment | |
| GB201322346D0 (en) | Combination treatment of cancer | |
| GB201306411D0 (en) | Treatment of inflammatory conditions | |
| TH1501001181A (th) | องค์ประกอบสำหรับรักษาโรคสะเก็ดเงิน |